© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Atlas Genetics Completes $20m Series C Fundraising
Posted 27th February 2015

Atlas Genetics Completes $20m Series C Fundraising

NULL

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Atlas Genetics Completes $20m Series C Fundraising
Image

Atlas Genetics Completes $20m Series C Fundraising

Atlas Genetics Ltd (“Atlas” or the “Company”), the ultra-rapid ‘test and treat’ molecular diagnostics company, announced the completion of a Series C financing, raising $20 million from a syndicate including existing investors and one new investor, RMI Partners.

New investor, RMI Partners, is a global life sciences venture capital firm, the largest in Eastern Europe. Existing investors include Novartis Venture Funds, Consort Medical plc, Johnson & Johnson Innovation – JJDC, Inc., LSP, BB Biotech Ventures and South West Ventures Fund. This newly announced financing follows on from the previously announced Series B fundraising of $25 million.

Atlas develops ultra-rapid point-of-care diagnostic tests for infectious diseases. The io® system is at an advanced stage of development and is expected to be launched in Europe with the first test for Chlamydia later this year. The Series C investment will be used to accelerate the launch of the io® system, initiate US clinical trials, and expand the menu of tests available initially in the STI (sexually transmitted infections) and HAI (hospital acquired infections) markets.

Dr John Clarkson, Chief Executive Officer of Atlas, commented: “We would like to thank our investors for their continued support and we are delighted to welcome RMI Partners to the syndicate. This is an exciting time for the Company as we prepare our first product, a test for the sexually transmitted infection Chlamydia, for launch in Europe later this year. The funds raised will enable us to commercialise our io® system and to build out a programme of much needed ‘test and treat’ assays in markets where time really does matter, both for the physician and for the patient.”

For more information about Atlas Genetics, please visit atlasgenetics.com.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
Making You Feel Happy, Healthy and Wealthy
Finance
10/02/2017Making You Feel Happy, Healthy and Wealthy

Agrawal Associates provides wealth management solutions for their clients. We chat with Girish Agrawal, who explains what the firm provides to clients.

Read Full PostRead - Eye Icon
Axiory Trading Academy and how does it help traders to become better
News
03/07/2023Axiory Trading Academy and how does it help traders to become better

Axiory Trading Academy and how does it help traders to become better Axiory is a Forex and CFD (Contract for Difference) broker that was conceived in 2011 and received a first customer in 2012. The broker is well regulated by the International Financial Servic

Read Full PostRead - Eye Icon
Large Sum Buys and Payments Abroad: How to Reduce Associated Fees
Finance
25/04/2022Large Sum Buys and Payments Abroad: How to Reduce Associated Fees

Buying an expensive item abroad may not sound like a logical go-to in the wake – or the midst, depending on your position – of a global pandemic. Supply chains have been chewed up, with worker and truck driver shortages, along with a microprocessor

Read Full PostRead - Eye Icon
Leading the Way in Fiduciary Services
Finance
06/03/2018Leading the Way in Fiduciary Services

Fiduciana Trust (Cyprus) Limited is a boutique Cyprus trustee and fiduciary services company with international coverage.

Read Full PostRead - Eye Icon
Pre-M&A Security Risks & Liabilities Assessment – 5 Tips & Best Practices
News
18/01/2024Pre-M&A Security Risks & Liabilities Assessment – 5 Tips & Best Practices

In the high-stakes world of mergers and acquisitions, cybersecurity risks and vulnerabilities have quietly emerged as a key consideration and a crucial cog that can make the whole deal fall flat. During the process of taking over a company, the acquirer assume

Read Full PostRead - Eye Icon
Secure Business Payments now available from PaymentEvolution
Finance
30/07/2015Secure Business Payments now available from PaymentEvolution

Pay suppliers, vendors and any open invoice directly to any bank account.

Read Full PostRead - Eye Icon
New Content Formats that Shake Up Traditional Media
Technology
01/12/2025New Content Formats that Shake Up Traditional Media

New content formats that shake up traditional media The way information is consumed is changing faster than ever. Where television, radio and newspapers once defined how people received information, people now choose when and how they consume content. These ne

Read Full PostRead - Eye Icon
One in Three Enterprise Devices Lack Encryption as Shadow AI Runs Wild 
News
01/10/2025One in Three Enterprise Devices Lack Encryption as Shadow AI Runs Wild 

Over one in three (35)% of enterprise PCs are not encrypted, despite standard security policies, amid millions of visits to generative AI platforms such as DeepSeek, often without formal approval or monitoring. 

Read Full PostRead - Eye Icon
The Numbers Game: How Accounting Has Changed in an Uncertain World
Finance
19/10/2022The Numbers Game: How Accounting Has Changed in an Uncertain World

Most of us take it for granted these days, but the rate of technological change in the past decade or more is astonishing. Super-fast internet, cloud storage, video streaming; just imagine what things will be like a decade from now.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow